ARHGAP23P1

Across TCGA pan-cancer cohorts, ARHGAP23P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ARHGAP23P1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where ARHGAP23P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ARHGAP23P1 is over-expressed in tumor.

LUSC, LUAD, and THCA are the cancer types where ARHGAP23P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARHGAP23P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	II,III,IV	+0.030	.008	4	view →
LUAD	Male	All	+0.015	.047	1	view →
THCA	Female	All	+0.009	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ARHGAP23P1–LUSC

Open the LUSC breakdown →